Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer

Archives of Internal Medicine
Vahakn B ShahinianJames S Goodwin

Abstract

Androgen deprivation therapy for prostate cancer has been associated with a spectrum of adverse effects, such as depression, memory difficulties, and fatigue, termed the androgen deprivation syndrome. Primary care physicians providing follow-up care for men with prostate cancer will be faced with managing these effects. We therefore sought to estimate the incidence of these effects and, by using a control group, ascertain whether these effects were related to androgen deprivation itself. We assessed the risk of physician diagnoses of depression, cognitive impairment, or constitutional symptoms in Medicare data following androgen deprivation using a sample of 50 613 men with incident prostate cancer and 50 476 men without cancer, from 1992 through 1997, in the linked Surveillance, Epidemiology, and End Results-Medicare database. Cox proportional hazards regression was used to adjust for confounding variables. Of men surviving at least 5 years after diagnosis, 31.3% of those receiving androgen deprivation developed at least 1 depressive, cognitive, or constitutional diagnosis compared with 23.7% in those who did not (P<.001). After adjustment for variables such as comorbidity, tumor characteristics, and age, the risks associated ...Continue Reading

References

Jul 21, 1998·Journal of Affective Disorders·S N Seidman, J G Rabkin
Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P StoneJ Hardy
Jan 9, 2001·Journal of Clinical Epidemiology·C N KlabundeJ L Warren
Feb 12, 2002·The Journal of Clinical Endocrinology and Metabolism·Matthew R SmithPhilip W Kantoff
May 2, 2002·Journal of the American Geriatrics Society·Kristine YaffeJane Cauley
Aug 21, 2002·Medical Care·Arnold L PotoskyColin B Begg
Nov 14, 2002·Urology·Aaron J MilbankEric A Klein
Apr 29, 2003·The Journal of Clinical Psychiatry·Marlene P Freeman, Scott A Freeman
Jul 3, 2003·Journal of the National Cancer Institute·Matthew R CooperbergPeter R Carroll
Sep 11, 2003·British Journal of Cancer·E SalminenM Nurmi
Oct 8, 2003·The Oncologist·Carrie A ThompsonCharles L Loprinzi
Feb 6, 2004·Archives of General Psychiatry·Molly M ShoresDaniel R Kivlahan
Apr 8, 2004·Current Opinion in Urology·Jeffrey M HolzbeierleinJ Brantley Thrasher
Jul 21, 2004·Journal of the National Cancer Institute. Monographs·Arati Rao, Harvey Jay Cohen
Jan 14, 2005·The New England Journal of Medicine·Vahakn B ShahinianJames S Goodwin

❮ Previous
Next ❯

Citations

Jun 22, 2006·Journal of the National Cancer Institute·Vahakn B ShahinianJames S Goodwin
Nov 25, 2006·BMJ : British Medical Journal·Timothy J Wilt, Ian M Thompson
Jul 16, 2008·BMC Health Services Research·Yong-fang KuoVahakn B Shahinian
Jan 11, 2012·Asian Journal of Andrology·Rowan G CaseyS Larry Goldenberg
Jan 18, 2013·Prostate Cancer·Matthew E Johnson, Mark K Buyyounouski
Jul 16, 2010·The Journal of Sexual Medicine·Stacy ElliottUNKNOWN ADT Survivorship Working Group
Feb 15, 2013·The Journal of Sexual Medicine·Landon W TrostWayne J G Hellstrom
Sep 6, 2011·Endocrinology and Metabolism Clinics of North America·Mathis Grossmann, Jeffrey D Zajac
Jul 14, 2010·The Journal of Urology·Ted A SkolarusBrent K Hollenbeck
Sep 24, 2015·Clinical Genitourinary Cancer·Giuseppe CollocaFranco Checcaglini
Feb 4, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·P Mongiat-ArtusUNKNOWN Membres du CCAFU
Oct 20, 2009·Critical Reviews in Oncology/hematology·Jean-Pierre DrozCora N Sternberg
Dec 17, 2008·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·T Lebret, A Méjean
Aug 19, 2008·Critical Reviews in Oncology/hematology·Gijsberta J van LondenSusan L Greenspan
Jul 25, 2006·Critical Reviews in Oncology/hematology·Shabbir M H AlibhaiZishan Allibhai
May 27, 2014·Archives of Psychiatric Nursing·Graham J McDougallForrest Scogin
Jan 31, 2012·Urologic Oncology·Lauren M WalkerJohn W Robinson
Oct 15, 2013·Journal of Medical Imaging and Radiation Oncology·David ChangNigel A Spry
Dec 18, 2019·Prostate Cancer and Prostatic Diseases·Charles RyanAlicia K Morgans
Mar 21, 2017·Medicine and Science in Sports and Exercise·Bradley A WallRobert U Newton
Feb 5, 2011·Molecular Endocrinology·Jennifer S DavisJohn J Krolewski
Jun 3, 2017·Medical Oncology·Pawel J WiechnoTomasz Demkow
Jul 2, 2017·Endocrine-related Cancer·Nicholas RussellMathis Grossmann
Jul 31, 2020·Physiological Reviews·Arianna GiacominiMarco Presta
Feb 10, 2021·The Korean Journal of Internal Medicine·In-Ho KimHyo Jin Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Related Papers

Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
Nathan A Hoag, Alan I So
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Celestia S Higano
© 2021 Meta ULC. All rights reserved